• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过合理设计来自巨大芽孢杆菌 YC4-R4 的醛酮还原酶来增强手性药物中间体的生物催化合成。

Enhancing the biocatalytic synthesis of chiral drug intermediate by rational design an aldo-keto reductase from Bacillus megaterium YC4-R4.

机构信息

College of Chemical Engineering, Huaqiao University, 668 Jimei Blvd., Xiamen, Fujian 361021, China; School of Environmental Science and Engineering, Shandong University, Qingdao 266237, China.

College of Chemical Engineering, Huaqiao University, 668 Jimei Blvd., Xiamen, Fujian 361021, China.

出版信息

Enzyme Microb Technol. 2022 Oct;160:110074. doi: 10.1016/j.enzmictec.2022.110074. Epub 2022 Jun 7.

DOI:10.1016/j.enzmictec.2022.110074
PMID:35709659
Abstract

In recent years, with the increasing number of patients with depression, the efficient synthesis of the first-line antidepressant drug duloxetine intermediate (S-N,N-dimethyl-3-hydroxy-3-(2-thienyl)-1-propanamine, S-DHTP) has attracted great attention. The wild-type AKR3-2-9 from Bacillus megaterium YC4-R4 exhibits high application potential of catalyzing N,N-dimethyl-3-keto-3-(2-thienyl)-1-propanamine (DKTP) to prepare S-DHTP, but there is still much room for improvement. In this work, rational design was carried out to enhance the catalytic potential of AKR3-2-9. Notably, compared to the wild-type AKR3-2-9, three mutants (Ile189Val, Asn256Asp, and Ile189Val + Asn256Asp) were obtained, and their catalytic efficiencies were increased by 1.3 times, 2.3 times, and 1.31 times, respectively. Besides, the thermal stability and organic solvent resistance were improved. More importantly, when the concentration of the substrate DKTP was 0.5 g/L, the catalytic yields of Ile189Val, Asn256Asp and Ile189Val + Asn256Asp were increased by 1.45 times, 1.86 times, and 2.05 times, respectively. Besides, the corresponding optical purities of the three mutants were 92.7 %, 94.3 % and 93.8 %. The above results indicated that the rational design of the AKR of Bacillus megaterium YC4-R4 enhanced its potential for biocatalytic preparation of S-DHTP.

摘要

近年来,随着抑郁症患者数量的增加,高效合成一线抗抑郁药度洛西汀中间体(S-N,N-二甲基-3-羟基-3-(2-噻吩基)-1-丙胺,S-DHTP)引起了极大的关注。来自巨大芽孢杆菌 YC4-R4 的野生型 AKR3-2-9 显示出催化 N,N-二甲基-3-酮-3-(2-噻吩基)-1-丙胺(DKTP)制备 S-DHTP 的高应用潜力,但仍有很大的改进空间。在这项工作中,进行了合理的设计以增强 AKR3-2-9 的催化潜力。值得注意的是,与野生型 AKR3-2-9 相比,获得了三个突变体(Ile189Val、Asn256Asp 和 Ile189Val+Asn256Asp),它们的催化效率分别提高了 1.3 倍、2.3 倍和 1.31 倍。此外,还提高了热稳定性和有机溶剂耐受性。更重要的是,当底物 DKTP 的浓度为 0.5 g/L 时,Ile189Val、Asn256Asp 和 Ile189Val+Asn256Asp 的催化产率分别提高了 1.45 倍、1.86 倍和 2.05 倍。此外,这三种突变体的相应光学纯度分别为 92.7%、94.3%和 93.8%。上述结果表明,对巨大芽孢杆菌 YC4-R4 的 AKR 进行合理设计增强了其生物催化制备 S-DHTP 的潜力。

相似文献

1
Enhancing the biocatalytic synthesis of chiral drug intermediate by rational design an aldo-keto reductase from Bacillus megaterium YC4-R4.通过合理设计来自巨大芽孢杆菌 YC4-R4 的醛酮还原酶来增强手性药物中间体的生物催化合成。
Enzyme Microb Technol. 2022 Oct;160:110074. doi: 10.1016/j.enzmictec.2022.110074. Epub 2022 Jun 7.
2
Gene mining, codon optimization and analysis of binding mechanism of an aldo-keto reductase with high activity, better substrate specificity and excellent solvent tolerance.基因挖掘、密码子优化及醛酮还原酶高活性、更好的底物特异性和出色溶剂耐受性的结合机制分析。
PLoS One. 2021 Dec 2;16(12):e0260787. doi: 10.1371/journal.pone.0260787. eCollection 2021.
3
Specific coenzyme preference switching for an aldo-keto reductase that synthesizes the chiral intermediate of duloxetine.用于合成度洛西汀手性中间体的醛酮还原酶的特定辅酶偏好性切换
Enzyme Microb Technol. 2023 Dec;171:110326. doi: 10.1016/j.enzmictec.2023.110326. Epub 2023 Sep 13.
4
Semi-rational engineering an aldo-keto reductase for stereocomplementary reduction of α-keto amide compounds.半理性工程醛酮还原酶用于立体互补还原α-酮酰胺化合物。
Microb Cell Fact. 2023 Oct 15;22(1):213. doi: 10.1186/s12934-023-02225-9.
5
Fluorescence-based screening for engineered aldo-keto reductase KmAKR with improved catalytic performance and extended substrate scope.基于荧光的筛选工程化的醛酮还原酶 KmAKR,以提高催化性能和扩展底物范围。
Biotechnol J. 2021 Sep;16(9):e2100130. doi: 10.1002/biot.202100130. Epub 2021 Jun 26.
6
Advances in aldo-keto reductases immobilization for biocatalytic synthesis of chiral alcohols.醛酮还原酶在固定化用于手性醇的生物催化合成方面的研究进展。
Int J Biol Macromol. 2024 Aug;274(Pt 1):133264. doi: 10.1016/j.ijbiomac.2024.133264. Epub 2024 Jun 18.
7
High-performance liquid chromatographic method for the simultaneous estimation of the key intermediates of duloxetine.同时测定度洛西汀关键中间体的高效液相色谱法
Talanta. 2005 Oct 31;67(5):975-8. doi: 10.1016/j.talanta.2005.04.020.
8
Improving the catalytic efficiency of aldo-keto reductase KmAKR towards t-butyl 6-cyano-(3R,5R)-dihydroxyhexanoate via semi-rational design.通过半理性设计提高醛酮还原酶 KmAKR 对叔丁基 6-氰基-(3R,5R)-二羟基己酸酯的催化效率。
Bioorg Chem. 2019 Sep;90:103018. doi: 10.1016/j.bioorg.2019.103018. Epub 2019 Jun 8.
9
Key sites insight on the stereoselectivity of four mined aldo-keto reductases toward α-keto esters and halogen-substituted acetophenones.关键部位洞察四种挖掘醛酮还原酶对α-酮酯和卤素取代苯乙酮的立体选择性。
Appl Microbiol Biotechnol. 2019 Aug;103(15):6119-6128. doi: 10.1007/s00253-019-09932-7. Epub 2019 Jun 4.
10
Structural-guided design to improve the catalytic performance of aldo-keto reductase KdAKR.基于结构导向的设计以提高醛酮还原酶KdAKR的催化性能。
Biotechnol Bioeng. 2023 Dec;120(12):3543-3556. doi: 10.1002/bit.28535. Epub 2023 Aug 29.